Paraneoplastic Autoimmune Neurological Syndromes and the Role of Immune Checkpoint Inhibitors
出版年份 2022 全文链接
标题
Paraneoplastic Autoimmune Neurological Syndromes and the Role of Immune Checkpoint Inhibitors
作者
关键词
-
出版物
Neurotherapeutics
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-01-19
DOI
10.1007/s13311-022-01184-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Neurotoxicities associated with immune checkpoint inhibitor therapy
- (2021) Sophie L. Duong et al. JOURNAL OF NEURO-ONCOLOGY
- Paraneoplastic Neurological Syndromes and Beyond Emerging With the Introduction of Immune Checkpoint Inhibitor Cancer Immunotherapy
- (2021) Cristina Valencia-Sanchez et al. Frontiers in Neurology
- Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
- (2021) Francesc Graus et al. Neurology-Neuroimmunology & Neuroinflammation
- Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
- (2021) Julie R Brahmer et al. Journal for ImmunoTherapy of Cancer
- Anti–Interleukin-6 and Janus Kinase Inhibitors for Severe Neurologic Toxicity of Checkpoint Inhibitors
- (2021) Alberto Picca et al. Neurology-Neuroimmunology & Neuroinflammation
- Severe neurological toxicity of immune checkpoint inhibitors: growing spectrum
- (2020) Divyanshu Dubey et al. ANNALS OF NEUROLOGY
- The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
- (2020) Eric Rondeau et al. KIDNEY INTERNATIONAL
- Anti-Hu-associated paraneoplastic syndromes triggered by immune-checkpoint inhibitor treatment
- (2020) Neus Mongay-Ochoa et al. JOURNAL OF NEUROLOGY
- Central nervous system complications associated with immune checkpoint inhibitors
- (2020) Alberto Vogrig et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Immune-related adverse events of checkpoint inhibitors
- (2020) Manuel Ramos-Casals et al. Nature Reviews Disease Primers
- Neurological autoimmunity and immune checkpoint inhibitors: Autoantibody profiles and outcomes
- (2020) Elia Sechi et al. NEUROLOGY
- Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitors
- (2019) Francesc Graus et al. Nature Reviews Clinical Oncology
- Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
- (2019) James F. Howard et al. NEUROLOGY
- Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
- (2019) Sean J. Pittock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phosphodiesterase 10A IgG
- (2019) Anastasia Zekeridou et al. NEUROLOGY
- Paraneoplastic Pemphigus: Paraneoplastic Autoimmune Disease of the Skin and Mucosa
- (2019) Jong Hoon Kim et al. Frontiers in Immunology
- A case series of PD-1 inhibitor-associated paraneoplastic neurologic syndromes
- (2019) AlexanderJ. Gill et al. JOURNAL OF NEUROIMMUNOLOGY
- Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
- (2019) Bruce A C Cree et al. LANCET
- Varied phenotypes and management of immune checkpoint inhibitor-associated neuropathies
- (2019) Divyanshu Dubey et al. NEUROLOGY
- Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors
- (2019) Alberto Vogrig et al. Neurology-Neuroimmunology & Neuroinflammation
- Epidemiology of paraneoplastic neurological syndromes: a population-based study
- (2019) Alberto Vogrig et al. JOURNAL OF NEUROLOGY
- Amphiphysin-IgG autoimmune neuropathy
- (2019) Divyanshu Dubey et al. NEUROLOGY
- Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
- (2019) Takashi Yamamura et al. NEW ENGLAND JOURNAL OF MEDICINE
- CRMP5-IgG–Associated Paraneoplastic Myelopathy With PD-L1 Inhibitor Therapy
- (2019) Amy Kunchok et al. JAMA Neurology
- Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study
- (2019) Guillaume Manson et al. Journal for ImmunoTherapy of Cancer
- Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration
- (2018) Mathilde Small et al. ACTA NEUROPATHOLOGICA
- Syndrome and outcome of antibody-negative limbic encephalitis
- (2018) F. Graus et al. EUROPEAN JOURNAL OF NEUROLOGY
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
- (2018) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Neurologic complications of immune checkpoint inhibitors
- (2018) Avi Fellner et al. JOURNAL OF NEURO-ONCOLOGY
- Acute cerebellitis after administration of nivolumab and ipilimumab for small cell lung cancer
- (2018) Tatsuhiko Naito et al. NEUROLOGICAL SCIENCES
- Encephalitis with mGluR5 antibodies
- (2018) Marianna Spatola et al. NEUROLOGY
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
- (2018) Leora Horn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
- (2018) Daniel Y. Wang et al. JAMA Oncology
- Complement-dependent bystander injury to neurons in AQP4-IgG seropositive neuromyelitis optica
- (2018) Tianjiao Duan et al. Journal of Neuroinflammation
- Blockade of IL-6 signaling in neuromyelitis optica
- (2018) Manabu Araki NEUROCHEMISTRY INTERNATIONAL
- Paraneoplastic neuronal intermediate filament autoimmunity
- (2018) Eati Basal et al. NEUROLOGY
- Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors
- (2017) D. Makarious et al. EUROPEAN JOURNAL OF CANCER
- Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature
- (2017) S. Cuzzubbo et al. EUROPEAN JOURNAL OF CANCER
- Acute Cerebellar Ataxia Induced by Nivolumab
- (2017) Reina Kawamura et al. INTERNAL MEDICINE
- Autoimmune limbic encephalitis with anti-contactin-associated protein-like 2 antibody secondary to pembrolizumab therapy
- (2017) Michael P Brown et al. JOURNAL OF NEUROIMMUNOLOGY
- Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
- (2017) James F Howard et al. LANCET NEUROLOGY
- Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases
- (2017) Divyanshu Dubey et al. NEUROLOGY
- Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan
- (2017) Shigeaki Suzuki et al. NEUROLOGY
- Anti‐Hu‐Associated Autoimmune Limbic Encephalitis in a Patient with PD‐1 Inhibitor‐Responsive Myxoid Chondrosarcoma
- (2017) Kyriakos P. Papadopoulos et al. ONCOLOGIST
- Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis
- (2017) James Larkin et al. ONCOLOGIST
- Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System
- (2017) Josep Dalmau et al. PHYSIOLOGICAL REVIEWS
- Neurological Complications Associated With Anti–Programmed Death 1 (PD-1) Antibodies
- (2017) Justin C. Kao et al. JAMA Neurology
- Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade
- (2017) Chipman RG Stroud et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group
- (2017) I. Puzanov et al. Journal for ImmunoTherapy of Cancer
- Hypophysitis Secondary to Cytotoxic T-Lymphocyte–Associated Protein 4 Blockade
- (2016) Patrizio Caturegli et al. AMERICAN JOURNAL OF PATHOLOGY
- The use of ipilimumab in patients with rheumatoid arthritis and metastatic melanoma
- (2016) B. Lee et al. ANNALS OF ONCOLOGY
- Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literature
- (2016) L. Spain et al. ANNALS OF ONCOLOGY
- Antibody-Mediated Thyroid Dysfunction During T-cell Checkpoint Blockade in Patients with Non-Small Cell Lung Cancer
- (2016) J.C. Osorio et al. ANNALS OF ONCOLOGY
- CTLA4 blockade elicits paraneoplastic neurological disease in a mouse model
- (2016) Lidia M. Yshii et al. BRAIN
- Human cerebrospinal fluid monoclonalN-methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis
- (2016) Jakob Kreye et al. BRAIN
- Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy
- (2016) Lisa Zimmer et al. EUROPEAN JOURNAL OF CANCER
- Rituximab treatment for autoimmune limbic encephalitis in an institutional cohort
- (2016) Woo-Jin Lee et al. NEUROLOGY
- Anti-LGI1 encephalitis
- (2016) Agnes van Sonderen et al. NEUROLOGY
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic Cancer
- (2016) Tanya J. Williams et al. JAMA Neurology
- Clinical and Immunological Features of Opsoclonus-Myoclonus Syndrome in the Era of Neuronal Cell Surface Antibodies
- (2016) Thaís Armangué et al. JAMA Neurology
- Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies
- (2016) Ding Chen et al. Journal of Clinical Medicine
- Immune-Related Adverse Events, Need for Systemic Immunosuppression, and Effects on Survival and Time to Treatment Failure in Patients With Melanoma Treated With Ipilimumab at Memorial Sloan Kettering Cancer Center
- (2015) Troy Z. Horvat et al. JOURNAL OF CLINICAL ONCOLOGY
- Encephalitis and AMPA receptor antibodies: Novel findings in a case series of 22 patients
- (2015) R. Hoftberger et al. NEUROLOGY
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation
- (2014) Nathalie E. Blachère et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Somatic Mutation of GRIN2A in Malignant Melanoma Results in Loss of Tumor Suppressor Activity via Aberrant NMDAR Complex Formation
- (2014) Todd D. Prickett et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy
- (2014) O. Tuohy et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Pituitary Expression of CTLA-4 Mediates Hypophysitis Secondary to Administration of CTLA-4 Blocking Antibody
- (2014) S. Iwama et al. Science Translational Medicine
- Alemtuzumab is effective against severe chronic lymphocytic leukaemia-associated paraneoplastic pemphigus
- (2013) R. Bech et al. BRITISH JOURNAL OF DERMATOLOGY
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
- (2013) Maarten J Titulaer et al. LANCET NEUROLOGY
- Encephalitis and GABAB receptor antibodies: Novel findings in a new case series of 20 patients
- (2013) R. Hoftberger et al. NEUROLOGY
- Association of the Autoimmune Disease Scleroderma with an Immunologic Response to Cancer
- (2013) C. G. Joseph et al. SCIENCE
- Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis
- (2012) C. G. Bien et al. BRAIN
- Paraneoplastic neurological syndromes
- (2012) Francesc Graus et al. CURRENT OPINION IN NEUROLOGY
- Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial
- (2012) Alasdair J Coles et al. LANCET
- Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica
- (2012) Bernd C. Kieseier et al. JAMA Neurology
- Purkinje Cell Cytoplasmic Autoantibody Type 1 Accompaniments
- (2011) Andrew McKeon ARCHIVES OF NEUROLOGY
- CSF interleukin-6 level predicts recovery from neuromyelitis optica relapse
- (2011) Akiyuki Uzawa et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Exome sequencing identifies GRIN2A as frequently mutated in melanoma
- (2011) Xiaomu Wei et al. NATURE GENETICS
- Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome
- (2011) E. Lancaster et al. NEUROLOGY
- Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica
- (2011) Norio Chihara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity
- (2010) Martin S. Weber et al. ANNALS OF NEUROLOGY
- Paraneoplastic Neurologic Syndrome in the PNS Euronetwork Database
- (2010) Bruno Giometto ARCHIVES OF NEUROLOGY
- Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
- (2010) Josep Dalmau et al. LANCET NEUROLOGY
- Antibody recycling by engineered pH-dependent antigen binding improves the duration of antigen neutralization
- (2010) Tomoyuki Igawa et al. NATURE BIOTECHNOLOGY
- Novel complement inhibitor limits severity of experimentally myasthenia gravis
- (2009) Jindrich Soltys et al. ANNALS OF NEUROLOGY
- Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis
- (2009) Michael P. Malter et al. ANNALS OF NEUROLOGY
- A prospective study of the presentation and management of dancing eye syndrome/opsoclonus–myoclonus syndrome in the United Kingdom
- (2009) K. Ki Pang et al. EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY
- Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model
- (2009) Yanping Hu et al. IMMUNOLOGY
- Cyclophosphamide and cancer: golden anniversary
- (2009) Ashkan Emadi et al. Nature Reviews Clinical Oncology
- CD19: a promising B cell target for rheumatoid arthritis
- (2009) Thomas F. Tedder Nature Reviews Rheumatology
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Paraneoplastic syndromes of the CNS
- (2008) Josep Dalmau et al. LANCET NEUROLOGY
- Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis
- (2007) M Seki et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now